REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026TRENDINGHexarelin: ↑↑ Surging ��� Trends score 100 as of May 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingEVENTpep-talk con ��� First US Peptide Convention · August 2026 · Anaheim CAFDAFDA advisory committee meetings scheduled: late July 2026REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026TRENDINGHexarelin: ↑↑ Surging ��� Trends score 100 as of May 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingEVENTpep-talk con ��� First US Peptide Convention · August 2026 · Anaheim CAFDAFDA advisory committee meetings scheduled: late July 2026

For research purposes only. Full disclaimer →

Back to transformations
BeforeBefore
AfterAfter
by Demo Gray Area Buyer · 8 days ago

16-week body recomposition with CJC-1295/Ipamorelin stack. Lost 7 lbs of fat while gaining 4 lbs of lean mass. Sleep quality improvement was the biggest surprise.

CJC-1295Ipamorelin
2026-01-26 → 2026-05-1816 weeks

Comments (2)

Demo Regulated Buyer·7 days ago

Great body composition changes. The DEXA data really adds credibility. Did you notice any water retention in the first few weeks?

Demo Manufacturer·7 days ago

The synergy between CJC-1295 DAC and Ipamorelin is well-documented. Your protocol timing looks optimized for pulsatile GH release.

Sign in to comment.